From Name:
From Email:
To Name:
To Email:

Optional Message:

US FDA approves biosimilar version of cancer drug Avastin

from Reuters

The U.S. Food and Drug Administration said it has approved Amgen Inc.’s biosimilar version of Roche Holding AG’s cancer drug Avastin. Amgen’s drug, Mvasi, was approved for multiple types of cancer and is the first biosimilar approved in the U.S. to treat cancer. Biosimilars are somewhat cheaper copies of biologic drugs. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063